Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.31T | 7.09B | 6.46B | 6.49B | 7.67B | 6.21B |
Gross Profit | 1.89B | 3.68B | 3.21B | 3.57B | 4.68B | 3.59B |
EBITDA | 2.39B | 2.98B | 2.52B | 3.14B | 3.91B | 2.94B |
Net Income | 2.05B | 2.10B | 1.79B | 1.56B | 3.08B | 2.37B |
Balance Sheet | ||||||
Total Assets | 14.34B | 13.47B | 12.28B | 11.64B | 12.51B | 10.66B |
Cash, Cash Equivalents and Short-Term Investments | 3.06B | 2.65B | 2.07B | 1.76B | 1.52B | 2.15B |
Total Debt | 0.00 | 278.70M | 308.50M | 329.60M | 249.20M | 154.10M |
Total Liabilities | 3.78B | 2.02B | 1.99B | 1.96B | 2.26B | 1.39B |
Stockholders Equity | 10.56B | 10.35B | 9.51B | 8.84B | 9.02B | 7.71B |
Cash Flow | ||||||
Free Cash Flow | 1.32B | 1.26B | 911.20M | 2.12B | 3.21B | 1.70B |
Operating Cash Flow | 1.53B | 1.69B | 1.22B | 2.36B | 3.45B | 1.92B |
Investing Cash Flow | -140.90M | -177.50M | -527.20M | -41.50M | -1.10B | -36.30M |
Financing Cash Flow | -1.05B | -936.60M | -1.08B | -2.08B | -2.99B | -1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $23.08B | 11.75 | 19.39% | 4.78% | 4.43% | 5.55% | |
79 Outperform | $24.03B | 14.77 | 13.47% | 2.39% | 3.44% | 16.76% | |
75 Outperform | $12.97B | 47.92 | 2.16% | 5.08% | 4.72% | -67.85% | |
70 Outperform | $22.47B | 18.16 | 23.07% | 2.25% | 81.86% | ― | |
68 Neutral | $31.51B | 12.45 | 10.94% | 2.74% | 11.66% | 67.88% | |
67 Neutral | $17.03B | 11.60 | 9.79% | 3.95% | 10.64% | 1.89% | |
65 Neutral | $17.93B | 27.46 | -2.89% | 2.82% | -18.21% | -116.73% |
T. Rowe Price held its annual stockholders meeting on May 8, 2025, where several key proposals were voted on. The election of directors saw most nominees receiving strong support, while a proposal for a shareholder approval requirement for excessive golden parachutes was largely rejected. Additionally, the compensation for named executive officers was approved, and KPMG LLP was ratified as the independent registered public accounting firm for 2025.
The most recent analyst rating on (TROW) stock is a Sell with a $107.00 price target. To see the full list of analyst forecasts on T Rowe Price stock, see the TROW Stock Forecast page.